COVID-19 Antibody Responses In Cystic Fibrosis

Clinical trial NCT05074680 · COMPLETED

Trial details

NCT number: NCT05074680
Sponsor: Insel Gruppe AG, University Hospital Bern
Status: COMPLETED
Study type: OBSERVATIONAL

Cystic Fibrosis

Start date: 2022-02-14
Primary completion: 2026-05-29
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.